ACTA2 and cancer: When looking into the CAF markers more specifically, COL1A1, ACTA2, and alpha-SMA are not significantly different in cancer tissues, compared to adjacent lung tissues, partially proving their roles may be allocated to the TME subgroup, not in whole cancer tissues or lung tissues.